Physician profile
Christopher Hamilton Smith
NPI 1831181486
$7,483.38
in general payments reported to CMS, 2019-2025
44 companies · $544 in 2025
The $544 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,078 · 2020: $882 · 2021: $1,324 · 2022: $1,454 · 2023: $758 · 2024: $444 · 2025: $544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,745.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $781.98 | 2019-2023 | Repatha |
| Janssen Pharmaceuticals, INC | $780.39 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $636.62 | 2019-2023 | |
| Cardiovascular Systems INC. | $525.11 | 2019-2023 | Diamondback Coronary |
| Pfizer INC. | $412.39 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $380.89 | 2019-2023 | Andexxa |
| Medtronic, INC. | $336.77 | 2021-2025 | Symplicity G3, Onyx Frontier, Corevalve Evolut R |
| Atricure, INC. | $334.20 | 2019-2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Merck Sharp & Dohme LLC | $320.34 | 2021-2023 | Verquvo |
| Abiomed | $317.39 | 2019-2025 | Impella |
| Cvrx, INC. | $268.48 | 2023-2025 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $257.08 | 2019-2025 | Lifevest |
| Gilead Sciences, INC. | $226.45 | 2019-2022 | |
| Abbott Laboratories | $197.10 | 2019-2023 | Diamondback Coronary |
| Sanofi-Aventis U.S. LLC | $171.81 | 2019 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $158.14 | 2020-2024 | Wolverine Coronary Cutting Balloon, Watchman Flx, Bodyguardian |
| Boehringer Ingelheim Pharmaceuticals, INC. | $151.73 | 2019-2023 | Jardiance |
| Alexion Pharmaceuticals, INC. | $125.00 | 2021 | |
| Amarin Pharma, INC. | $107.20 | 2019-2022 | |
| Philips North America LLC | $105.31 | 2022-2025 | (5091) Amb Mon & Diag Und, Ambulatory Monitoring & Diagnostics Undivided |
| Medtronic Vascular, INC. | $86.99 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $75.81 | 2022-2023 | |
| Shockwave Medical, INC | $71.99 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biolase, INC. | $68.95 | 2020 | |
| Impulse Dynamics (USA) INC. | $67.37 | 2022-2025 | Optimizer, Optimizer |
| Regeneron Healthcare Solutions, INC. | $57.34 | 2019 | |
| Kestra Medical Technology Services, INC. | $48.91 | 2023-2025 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $43.27 | 2022 | |
| Surmodics, INC. | $41.52 | 2023 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy, Sublime Radial Access 018 Rx Pta Dilatation Catheter |
| Lundbeck LLC | $39.58 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $37.02 | 2022 | |
| Dexcom, INC. | $33.61 | 2024 | Dexcom G6 Transmitter |
| Heartflow, INC. | $26.52 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $25.08 | 2024 | Arcalyst |
| Chiesi USA, INC. | $23.96 | 2019 | |
| Teleflex LLC | $22.47 | 2025 | Trapliner |
| Daiichi Sankyo INC. | $20.10 | 2023 | Injectafer |
| Cmp Pharma, INC. | $19.42 | 2022 | |
| Irhythm Technologies, INC. | $16.69 | 2024 | Zio Monitor, Zio Xt Patch |
| Scpharmaceuticals INC. | $16.51 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $16.48 | 2021 | |
| Abbvie INC. | $15.84 | 2022 | |
| Esperion Therapeutics, INC. | $13.57 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.